NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-142554

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedProphylaxis of new type of influenza infection
Date of first enrollment29/5/2014
Target sample size150
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : KIB-PCI (H5N1 influenza vaccin) Dosage And administration of the intervention : Intramuscular Control intervention name : null

Outcome(s)

Primary OutcomeSRH antibody titer
Secondary OutcomeNeutralizing antibody titer

Key inclusion & exclusion criteria

Age minimum
Age maximum19
GenderBOTH
Include criteriaHealthy Japanese children
Exclude criteria1) Subjects with history of H5N1 influenza 2) Subjects with history of H5N1 influenza vaccination

Related Information

Contact

public contact
Name DAIICHI SANKYO Co.,Ltd. Contact for Clinical Trial Information
Address http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation